The FDA told influenza vaccine makers they should add a warning about an increased febrile seizure risk in babies and ...

The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to suicide among users of ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

On Jan. 6, the FDA classified the recall as Class I, the most high-risk recall category. Consuming the product could cause ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts ...

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

The FDA said it wants suicide warnings to be taken off some popular weight-loss medications following a comprehensive safety ...

HHS has denied any nefarious intent behind the FDA’s removal of the page. In a statement to Ars Technica, a representative ...

But, under anti-vaccine Health Secretary Robert F. Kennedy Jr.—who has numerous ties to the wellness industry—that FDA ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.

The removal request is based on a ‘comprehensive review of available data’ that showed no increased risk of suicidal ideation and behavior.